BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Curis, Inc. 

61 Moulton Street

Cambridge  Massachusetts  02138  U.S.A.
Phone: 617-876-0086 Fax: 617-876-0866


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Curis, Inc. (CRIS) To Present At The 27th Annual Roth Conference 3/4/2015 8:37:36 AM
Curis, Inc. (CRIS) Announces Closing Of Public Offering Of Common Stock 3/3/2015 7:18:01 AM
Curis, Inc. (CRIS) To Present At The Cowen and Company 35th Annual Health Care Conference 2/27/2015 7:15:59 AM
Curis, Inc. (CRIS) Reports Fourth Quarter And Year-End 2014 Financial Results 2/25/2015 8:35:15 AM
Curis, Inc. (CRIS) Announces Proposed Public Offering Of Common Stock 2/25/2015 7:46:42 AM
Curis, Inc. (CRIS) Prices Public Offering Of Common Stock 2/25/2015 7:44:54 AM
Curis, Inc. (CRIS) To Present At The 2015 Biotechnology Industry Organization (BIO) CEO And Investor Conference 2/3/2015 8:31:57 AM
Curis, Inc. (CRIS), Aurigene Discovery Technologies Limited Forge $415 Million+ Immuno-Oncology Pact 1/21/2015 5:53:42 AM
Curis, Inc. (CRIS) Announces Dosing Of First Patient In Phase 1 Trial Of CUDC-907 In Patients With Advanced/ Relapsed Solid Tumors 12/18/2014 7:38:21 AM
Curis, Inc. (CRIS) To Present At Upcoming Investor Conferences 11/26/2014 11:45:21 AM
12345678910...